Do Migraine Patients Reach Sustained Pain Relief?
Achieving pain freedom at 2 hours and sustained pain response at 24 hours are important outcomes of any acute migraine therapy.
Nerve Blocks for Headaches & Migraine
Nerve blocks are often used in adults and children to treat headaches, but few data look at practice patterns in a pediatric setting.
Neuro News Roundup: New MS Test & Stroke Risk
Studies include a potential test for MS, a link between headaches and hypothyroidism, and a risk prediction scale for stroke patients.
ANA 2016: Risk Factors with Neurological Disorders
Award-winning posters presented during the American Neurological Association Annual Meeting discussed risks in stroke, MS, and migraine.
Interesting Neuro: Stroke Therapy & Zika Updates
Oct. news includes an approved deep brain stimulation system for movement disorders & biomarkers that improve risk assessment in atrial fibrillation.
Evaluation of PACAP Levels in Chronic Migraine
Researchers evaluated whether blood levels of PACAP could serve as a biomarker for parasympathetic activation in migraine headaches.
Triptan Use in Adults with Migraine and CV Risk Factors
Triptans are contraindicated with certain CV risk factors, however, there are few data looking at the rate of triptans use among this population.
By clicking Accept, you agree to become a member of the UBM Medica Community.